Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including the FDA approving a new Merck treatment, Robinhood offering a credit card, nCino spiking on strong guidance, and GameStop tanking on a huge miss. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the NCAA NIT, and the top 5 draft QBs in the draft. Stay on the cutting edge with Rebel's Edge.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.